An Apple Watch, which integrates easily into the Dexcom CGM ecosystem ... anyone trying to hack diabetes care. Until then, if you need a primer on continuous glucose monitoring, we’re happy ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2024 investor ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

In March 2024, the FDA approved the first over-the-counter continuous glucose monitors (CGMs). These devices open the door ... I just started testing Dexcom’s Stelo, Lingo’s main OTC ...

SAN FRANCISCO—After spending the past year extending its portfolio of continuous glucose monitors to include people who may not have diabetes, Dexcom said it expects to see more than $4.03 ...

Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...

North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate ...

Latin America continuous glucose monitoring device market is estimated to be valued at US$ 219.3 mn in 2025 and is expected to exhibit a CAGR of 15.8% by 2032 BURLINGAME, CA, UNITED STATES ...

Dexcom has shaken off the lower sales outlook that plagued its share price in 2024 as the diabetes ... last six months, we're very excited for our 2025 opportunity.” GlobalData medical device ...